Description

Quantitative data from a study on early intervention with Kan Jang® to treat upper, presenting measured outcomes relevant to the investigation of BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .

More Figures from This Paper

Figure 1

Experimental results examining early intervention with Kan Jang® to treat upper, with data points illustrating key findings related to BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .

chart

Figure 2

Statistical analysis from research investigating early intervention with Kan Jang® to treat upper, comparing treatment groups and control conditions.

chart

Figure 3

Measured parameters from a study evaluating early intervention with Kan Jang® to treat upper, contributing to the overall assessment of BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .

chart

Figure 4

Graphical representation of outcomes in a study of early intervention with Kan Jang® to treat upper, highlighting trends observed across experimental conditions.

chart

Figure 6

chart

Figure 7

Statistical analysis from research investigating early intervention with Kan Jang® to treat upper, comparing treatment groups and control conditions.

chart

Figure 5

Chart

1185 × 1678px · 701.8 KB

Source Paper

Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, quadruple-blind study.

Journal of traditional and complementary medicine (2021)

PMID: 34765519

DOI: 10.1016/j.jtcme.2021.06.001

Cite This Figure

![Figure 5: Quantitative data from a study on early intervention with Kan Jang® to treat upper, presenting measured outcomes relevant to the investigation of BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .](https://pdfs.citedhealth.com/figures/34765519/154.png)

> Source: Mikayel Narimanyan et al. "Early intervention with Kan Jang® to treat upper-respiratory tract infections: A." *Journal of traditional and complementary medicine*, 2021. PMID: [34765519](https://pubmed.ncbi.nlm.nih.gov/34765519/)

<figure>
  <img src="https://pdfs.citedhealth.com/figures/34765519/154.png" alt="Quantitative data from a study on early intervention with Kan Jang® to treat upper, presenting measured outcomes relevant to the investigation of BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, ." />
  <figcaption>Figure 5. Quantitative data from a study on early intervention with Kan Jang® to treat upper, presenting measured outcomes relevant to the investigation of BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .<br>  Source: Mikayel Narimanyan et al. "Early intervention with Kan Jang® to treat upper-respiratory tract infections: A." <em>Journal of traditional and complementary medicine</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34765519/">34765519</a></figcaption>
</figure>

Related Evidence

Andrographis for Upper Respiratory Tract Infections

Grade B · 7 studies